-Parties: The plaintiffs were AstraZeneca Canada Inc. and Kudos Pharmaceuticals Limited. The defendant was Zydus Lifesciences Limited.

-Subject Matter: This is a patent infringement action before the Federal Court under the Patented Medicines (Notice of Compliance) Regulations involving AstraZeneca Canada Inc. and Kudos Pharmaceuticals Limited as plaintiffs and Zydus Lifesciences Limited as defendant. The case concerns allegations of future infringement and the defendant’s statement of defence asserting non-infringement and multiple invalidity grounds relating to Canadian Patent No. 400 for olaparib (LYNPARZA®) pharmaceutical formulations. The case is ongoing.

-Date: The hearing was set on May 20, 2026.

-Venue: This was a federal case before the Federal Court.

-Amount: No financial award was specified.